Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
243.47
-4.06 (-1.64%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Jazz Pharmaceuticals Market Cap
Jazz Pharmaceuticals has a market cap or net worth of $15.29 billion as of July 20, 2026. Its market cap has increased by 119.85% in one year.
Market Cap
15.29B
Enterprise Value
17.84B
1-Year Change
119.85%
Ranking
Category
Stock Price
$243.47
ChartMarket Cap Chart
Since June 1, 2007, Jazz Pharmaceuticals's market cap has increased from $435.30M to $15.29B, an increase of 3,413.49%. That is a compound annual growth rate of 20.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 15.28B | 47.88% |
| Dec 31, 2025 | 10.33B | 38.75% |
| Dec 31, 2024 | 7.45B | -3.86% |
| Dec 29, 2023 | 7.74B | -22.80% |
| Dec 30, 2022 | 10.03B | 28.09% |
| Dec 31, 2021 | 7.83B | -14.84% |
| Dec 31, 2020 | 9.20B | 8.89% |
| Dec 31, 2019 | 8.45B | 12.94% |
| Dec 31, 2018 | 7.48B | -7.37% |
| Dec 29, 2017 | 8.07B | 23.62% |
| Dec 30, 2016 | 6.53B | -24.46% |
| Dec 31, 2015 | 8.64B | -12.72% |
| Dec 31, 2014 | 9.90B | 35.42% |
| Dec 31, 2013 | 7.31B | 137.27% |
| Dec 31, 2012 | 3.08B | 89.28% |
| Dec 30, 2011 | 1.63B | 112.63% |
| Dec 31, 2010 | 765.90M | 213.64% |
| Dec 31, 2009 | 244.20M | 340.00% |
| Dec 31, 2008 | 55.50M | -84.62% |
| Dec 31, 2007 | 360.90M | -17.09% |
| Jun 1, 2007 | 435.30M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 17.31B |
| BridgeBio Pharma | 15.83B |
| Ascendis Pharma | 15.64B |
| Exelixis | 13.96B |
| Madrigal Pharmaceuticals | 12.35B |
| ABIVAX Société Anonyme | 11.61B |
| BioMarin Pharmaceutical | 11.43B |
| Axsome Therapeutics | 11.41B |